Вид документа : Статья из журнала Шифр издания : Автор(ы) : Kornatska A. G., Flaksemberg M. A., Chubei G. V., Trokhymovych O. V., Rossokha Z. I., Fishchuk L. Ye., Medvedieva N. L., Vershyhora V. O., Gorovenko N. G. Заглавие : A variant of TP53 gene (RS 1625895, 13494GA) is associated with neoplasm localization in patients with uterine leiomyoma Место публикации : Experimental Oncology. - К., 2021. - Том 43, N 2. - С. 155-158 (Шифр ЕУ12/2021/43/2) MeSH-главная: ЛЕЙОМИОМА -- LEIOMYOMA МАТКИ НОВООБРАЗОВАНИЯ -- UTERINE NEOPLASMS Аннотация: Uterine leiomyoma (UL) is the most common benign neoplasm of the uterus. It is still unknown surely what exactly initiates transformation of the uterine myometrial cells into UL. Aim: To study the effect of the TP53 gene variants on the risk of development and clinical features of UL. Materials and Methods: Case-control study was performed using molecular genetic analyses of variants rs1042522 (119 GC) and rs1625895 (13494GA) of TP53 gene in patients with UL and comparison group of healthy women. Results: Investigated TP53 gene variants were not associated with the risk of UL development. The patients with the 13494GG genotype (rs1625895) had significantly more often subserous UL (р 0.05). In patients with heterozygous variant of TP53 — 13494GA genotype (rs1625895) intramural UL was observed (р 0.05). Conclusions: The rs1625895 (13494GA) variant of TP53 gene was associated with UL localization. The identified dependence of the UL localization on the TP53 gene variant could be useful for personalized approach to treatment Доп.точки доступа: Kornatska, A. G. Flaksemberg, M. A. Chubei, G. V. Trokhymovych, O. V. Rossokha, Z. I. Fishchuk, L. Ye. Medvedieva, N. L. Vershyhora, V. O. Gorovenko, N. G.